How Long Until Wegovy Starts Working?
Wegovy (semaglutide) begins suppressing appetite and promoting weight loss within the first 4 weeks for most patients, with noticeable effects like reduced hunger often reported in 1-2 weeks.[1][2] Clinical trials show an average 5% body weight reduction by week 12-20 at maintenance doses, building gradually as the dose ramps up weekly from 0.25 mg to 2.4 mg over 16 weeks to minimize side effects.[3]
What Do Patients Notice First?
Early signs include feeling fuller sooner and less frequent hunger pangs, typically starting in week 1-4. Some report 1-2 pounds lost in the first month, though this varies by diet, exercise, and starting weight. Full effects peak after 68 weeks in trials, with average 15% total weight loss.[1][4]
Why the Gradual Dose Increase?
Starting low prevents nausea and GI issues. Week 1: 0.25 mg (minimal effect). By week 5: 1 mg (appetite suppression strengthens). Maintenance at 2.4 mg sustains results. Skipping escalation risks intolerance.[2][3]
When Do You See Significant Weight Loss?
- Month 1: 1-4 lbs, mostly water and appetite drop.
- Month 3: 5-8% body weight.
- 6+ months: 10-15% with lifestyle changes; plateaus possible without them.[1][4]
Trials like STEP 1 (1,961 adults) confirm 68-week results but note 20-30% drop out rate due to side effects.[3]
Factors Affecting How Quickly It Works
Higher BMI patients or those with insulin resistance may respond slower initially but catch up by month 3. Combining with 500-calorie deficit diet and exercise speeds results by 20-30%. Age, genetics, and adherence matter—missing doses delays progress.[2][5]
What If It Doesn't Work Right Away?
Up to 20% see minimal effects by week 12; doctors may adjust dose or switch meds. No response after 16 weeks warrants reevaluation for underlying issues like thyroid problems.[5] Steady blood sugar improvements start week 4, aiding diabetes control.[1]
How Does Wegovy Compare to Ozempic or Mounjaro?
Wegovy (weekly 2.4 mg semaglutide) matches Ozempic's 1-2 week onset but higher dose yields more weight loss (15% vs. 10%). Mounjaro (tirzepatide) acts faster (appetite drop in days) with 20%+ loss, but higher nausea risk.[4][6]
[1]: Novo Nordisk Wegovy Prescribing Information
[2]: NEJM STEP 1 Trial
[3]: FDA Wegovy Label
[4]: Drugs.com Wegovy Timeline
[5]: Mayo Clinic Semaglutide Guide
[6]: NEJM SURMOUNT-1 Trial (Mounjaro)